Bank Of America Corp Milestone Pharmaceuticals Inc. Transaction History
Bank Of America Corp
- $1.33 Trillion
- Q2 2025
A detailed history of Bank Of America Corp transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 8 shares of MIST stock, worth $14. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 39,396
99.98%
Holding current value
$14
Previous $31,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$8.7 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.39 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.14 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.45 Million1.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.99 Million1.67% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $52.5M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...